Lindsay E Clegg
9PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Jun 26, 2024
AZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults.Yingyun Cai, Seme Diallo, Kim Rosenthal
|Mar 27, 2024
Accelerating therapeutics development during a pandemic: population pharmacokinetics of the long-acting antibody combination AZD7442 (tixagevimab/cilgavimab) in the prophylaxis and treatment of COVID-19.Lindsay E Clegg, Oleg Stepanov, Henning Schmidt
|Dec 05, 2023
Potassium homeostasis and therapeutic intervention with sodium zirconium cyclosilicate: A model-informed drug development case study.Lindsay E Clegg, Lulu Chu, Mats Nagard
|Jan 04, 2021
Cardiovascular and renal safety of metformin in patients with diabetes and moderate or severe chronic kidney disease: Observations from the EXSCEL and SAVOR-TIMI 53 cardiovascular outcomes trials.Lindsay E Clegg, Yankang Jing, Robert C Penland
|Aug 18, 2020
Effect of once-weekly exenatide on estimated glomerular filtration rate slope depends on baseline renal risk: A post hoc analysis of the EXSCEL trial.Annemarie B van der Aart-van der Beek, Lindsay E Clegg, Robert C Penland
|Jan 09, 2020
Prediction and validation of exenatide risk marker effects on progression of renal disease: Insights from EXSCEL.Nienke M A Idzerda, Lindsay E Clegg, Adrian F Hernandez
Pageof 2
Frequent Collaborators
4 joint publications
Robert C Penland
4 joint publications
Rury R Holman
3 joint publications
Hiddo J L Heerspink
1 joint publications
David W Boulton
1 joint publications
Seme Diallo
1 joint publications
Kuishu Ren
1 joint publications
Daniel J Flores
1 joint publications
Andrew Dippel
1 joint publications
Vaheh Oganesyan
1 joint publications
Rakesh Choudhary
